ABC | Volume 113, Nº6, December 2019

Original Article Barbosa et al Nrf2, NF- κ B and PPAR β / δ in CAD patients Arq Bras Cardiol. 2019; 113(6):1121-1127 22. Keys A, Fidanza F, Karvonen MJ, Kimura N, Taylor HL. Indices of relative weight and obesity. J Chronic Dis. 1972;25(6):329–43. 23. Malachias MV, Plavnik FL, Machado CA, Malta D, Scala LC, Fuchs S, et al. 7th Brazilian Guideline of Arterial Hypertension: Chapter 1 - Concept, Epidemiology and Primary Prevention. Arq Bras Cardiol. 2016;107(3):1–6. 24. FriedewaldWT, Levy RI, FredricksonDS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502. 25. Cardozo LFMF, Stockler-Pinto MB, Mafra D. Brazil nut consumption modulates Nrf2 expression in hemodialysis patients: A pilot study. Mol Nutr Food Res. 2016;60(7):1719–24. 26. Pedruzzi LM, Cardozo LF, Daleprane JB, Stockler-Pinto MB, Monteiro EB, Leite M Jr, et al. Systemic inflammation and oxidative stress in hemodialysis patients are associated with down-regulation of Nrf2. J Nephrol. 2015;28(4):495-501. 27. Mozzini C, Fratta Pasini A, Garbin U, Stranieri C, Pasini A, Vallerio P, et al. Increased endoplasmic reticulum stress and Nrf2 repression in peripheral bloodmononuclear cells of patients with stable coronary artery disease. Free Radic Biol Med. 2014 Mar;68:178–85. 28. Visvikis-Siest S, Marteau J-B, Samara A, Berrahmoune H, Marie B, Pfister M. Peripheral bloodmononuclear cells (PBMCs): a possiblemodel for studying cardiovascular biology systems. Clin ChemLabMed. 2007;45(9):1154–68. 29. Li C, Browder W, Kao RL. Early activation of transcription factor NF- kappaB during ischemia in perfused rat heart. Am J Physiol. 1999;276(2 Pt 2):H543–552. 30. Wilson SH, Best PJM, Edwards WD, Holmes DR, Carlson PJ, Celermajer DS, et al. Nuclear factor-kappaB immunoreactivity is present in human coronary plaque and enhanced in patients with unstable angina pectoris. Atherosclerosis. 2002;160(1):147–53. 31. Gareus R, Kotsaki E, Xanthoulea S, van der Made I, Gijbels MJJ, Kardakaris R, et al. Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis. Cell Metab. 2008;8(5):372–83. 32. Malhotra D, Thimmulappa R, Navas-Acien A, Sandford A, Elliott M, Singh A, et al. Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1. Am J Respir Crit Care Med. 2008;178(6):592–604. 33. Suzuki M, Betsuyaku T, Ito Y, Nagai K, Nasuhara Y, Kaga K, et al. Down- regulatedNF-E2-related factor2 inpulmonarymacrophagesofagedsmokers and patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2008;39(6):673–82. 34. ZhuH, Jia Z, Zhang L, YamamotoM, Misra HP, TrushMA, et al. Antioxidants and phase 2 enzymes in macrophages: regulation by Nrf2 signaling and protection against oxidative and electrophilic stress. Exp Biol Med (Maywood). 2008;233(4):463–74. 35. Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Johansen K, et al. ’United States Renal Data System2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis. 2012;59(1 Suppl 1):A7, e1–420. 36. Ishikawa K, Maruyama Y. Heme oxygenase as an intrinsic defense system in vascular wall: implication against atherogenesis. J Atheroscler Thromb. 2001;8(3):63–70. 37. JyrkkänenH-K,KansanenE,InkalaM,KiveläAM,HurttilaH,HeinonenSE,etal. Nrf2 regulates antioxidant gene expression evoked by oxidized phospholipids in endothelial cells andmurine arteries in vivo. Circ Res. 2008;103(1):e1–9. 38. Moon GJ, Kim SJ, Cho YH, Ryoo S, Bang OY. Antioxidant effects of statins in patients with atherosclerotic cerebrovascular disease. J Clin Neurol. 2014;10(2):140–7. 39. IvanovM, Mihailović-Stanojević N, GrujićMilanović J, Jovović Đ , Marković- Lipkovski J, Ćirović S, et al. Losartan improved antioxidant defense, renal function and structure of postischemic hypertensive kidney. PloS One. 2014;9(5):e96353. 40. Suh JH, Shenvi SV, Dixon BM, Liu H, Jaiswal AK, Liu R-M, et al. Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. Proc Natl Acad Sci U S A. 2004;101(10):3381–6. 41. Fiorentino TV, Prioletta A, Zuo P, Folli F. Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases. Curr PharmDes. 2013;19(32):5695–703. 42. Wagner KD, Vukolic A, Baudouy D, Michiels JF, Wagner N. Inducible Conditional Vascular-Specific Overexpression of Peroxisome Proliferator- Activated Receptor Beta/Delta Leads to Rapid Cardiac Hypertrophy. PPAR Res. 2016;2016:7631085. 43. Burkart EM, Sambandam N, Han X, Gross RW, Courtois M, Gierasch CM, et al. Nuclear receptors PPARbeta/delta and PPARalpha direct distinct metabolic regulatory programs in the mouse heart. J Clin Invest. 2007;117(12):3930–9. 44. Tan NS, Michalik L, Noy N, Yasmin R, Pacot C, HeimM, et al. Critical roles of PPAR beta/delta in keratinocyte response to inflammation. Genes Dev. 2001;15(24):3263–77. 45. Jiang B, Liang P, Zhang B, Huang X, Xiao X. Enhancement of PPAR-beta activity by repetitive low-grade H(2)O(2) stress protects human umbilical vein endothelial cells from subsequent oxidative stress-induced apoptosis. Free Radic Biol Med. 2009;46(5):555–63. 46. Reuland DJ, McCord JM, Hamilton KL. The role of Nrf2 in the attenuation of cardiovascular disease. Exerc Sport Sci Rev. 2013;41(3):162–8. 47. Cardozo LF, Pedruzzi LM, Stenvinkel P, Stockler-Pinto MB, Daleprane JB, LeiteM, et al. Nutritional strategies tomodulate inflammation and oxidative stress pathways via activation of the master antioxidant switch Nrf2. Biochimie. 2013;95(8):1525–33. 1126